Swiss law

DGAP-News: MAX Automation SE publishes statement in connection with an application to add to the agenda of the Annual General Meeting on 28 May 2021

Tuesday, May 4, 2021 - 2:17pm

The company has complied with this request.\nThe subject of the special audit is to be various facets of the acquisition of the AIM Group by the then M.A.X.

Key Points: 
  • The company has complied with this request.\nThe subject of the special audit is to be various facets of the acquisition of the AIM Group by the then M.A.X.
  • Lawyers and auditors commissioned by the shareholder Mr. Klaus Schulze had several days to review the extensive documentation.
  • The action for admittance to court pursuant to Section 148 of the German Stock Corporation Act (AktG) was then not pursued further.\nThe Supervisory Board of MAX Automation SE therefore expresses its lack of understanding that the acquisition of the AIM Group by the then M.A.X.
  • Automation AG from a company of the G\xc3\xbcnther Group in 2013 is now to be made the subject of a special audit.

DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad publishes annual report for 2020

Tuesday, March 23, 2021 - 4:07pm

DGAP-News: Heliad Equity Partners GmbH & Co. KGaA / Key word(s): Annual Report/Annual Results

Key Points: 
  • DGAP-News: Heliad Equity Partners GmbH & Co. KGaA / Key word(s): Annual Report/Annual Results
    Heliad Equity Partners GmbH & Co. KGaA: Heliad publishes annual report for 2020
    The issuer is solely responsible for the content of this announcement.
  • Frankfurt am Main, March 23, 2020 - Heliad Equity Partners GmbH & Co KGaA (ISIN: DE000A0L1NN5, HPBK.GR) today publishes its figures for the 2020 financial year.
  • As of December 31, 2020, Heliad had cash and cash equivalents of EUR 24.5 million (PY: EUR 1.2 million).
  • Heliad Equity Partners GmbH & Co. KGaA
    23.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

DGAP-News: CatalYm Announces Key Management and Board Changes

Monday, March 1, 2021 - 2:07pm

Munich, Germany, March 1, 2021 - CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced changes to the management team and supervisory board.

Key Points: 
  • Munich, Germany, March 1, 2021 - CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced changes to the management team and supervisory board.
  • Dr. Manfred Ruediger stepped down as Chief Executive Officer of CatalYm with effect from 28 February 2021 to pursue new business opportunities.
  • In the meantime, Anne Burger, CFO of CatalYm, will take responsibility for the company as Managing Director.
  • As Partner of Forbion, he was one of the founding investors and fulfilled the role of Chairman and Supervisory Board member since the inception of CatalYm mid-2016.

DGAP-News: MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021

Tuesday, January 12, 2021 - 1:11pm

MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021

Key Points: 
  • MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021
    The issuer is solely responsible for the content of this announcement.
  • Dr. York Dhein will join on April 1st, 2021
    In its meeting on January 11, 2021, the Supervisory Board of MEDICLIN Aktiengesellschaft appointed Dr. med.
  • York Dhein as additional member to the Management Board of MEDICLIN AG.
  • This was followed by five years as a consultant in the health care business of an international management consulting company.

DGAP-News: paragon Holds Virtual Annual General Meeting in Delbrück

Tuesday, September 15, 2020 - 1:08pm

- A look back at Automotive business in 2019: 16% revenue growth despite a market that has shrunk by 6% and one-time special expenses

Key Points: 
  • - A look back at Automotive business in 2019: 16% revenue growth despite a market that has shrunk by 6% and one-time special expenses
    Delbrck, Germany, September 15, 2020 - paragon [ISIN DE0005558696] held its Annual General Meeting for 2020 today.
  • For this virtual format, the showroom in the headquarter in Delbrck was transformed into a temporary television studio.
  • Hopefully, this year's format will remain an exception," explains Klaus Dieter Frers, founder and Chairman of the Board of paragon.
  • The Annual General Meeting expressed its confidence in the members of the Management and the Supervisory Board of paragon GmbH & Co. KGaA for fiscal year 2019 by a large majority and approved all items on the agenda.

DGAP-News: Jefferies International Limited: Private placement in flatex AG completed

Friday, July 3, 2020 - 8:01am

The core shareholders of flatex AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR), GfBk Gesellschaft fr Brsenkommunikation mbH ('GfBk') and Heliad Equity Partners GmbH & Co. KGaA ('Heliad'), sold in total 2,300,000 shares in flatex (approximately 11.7% of all outstanding shares) in a private placement to institutional investors.

Key Points: 
  • The core shareholders of flatex AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR), GfBk Gesellschaft fr Brsenkommunikation mbH ('GfBk') and Heliad Equity Partners GmbH & Co. KGaA ('Heliad'), sold in total 2,300,000 shares in flatex (approximately 11.7% of all outstanding shares) in a private placement to institutional investors.
  • Following the placement, the free float in flatex AG will represent more than 70% of outstanding shares.
  • Mr. Frtsch will hold after the private placement directly as well as indirectly via GfBk around 18.6%, Heliad will continue to hold around 7.3%.
  • Jefferies acted as Sole Global Coordinator and Mainfirst as Co-Bookrunner in connection with the placement.

DGAP-News: CompuGroup Medical SE: Annual General Meeting approves change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) and dividend at previous year's level

Wednesday, May 13, 2020 - 5:05pm

CompuGroup Medical SE: Annual General Meeting approves change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) and dividend at previous year's level

Key Points: 
  • CompuGroup Medical SE: Annual General Meeting approves change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) and dividend at previous year's level
    The issuer is solely responsible for the content of this announcement.
  • CompuGroup Medical SE, one of the leading eHealth companies worldwide, held its Annual General Meeting, virtually, today for the first time.
  • With a majority of 75.67 %, the shareholders of the MDAX company decided to change its legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA).
  • They will hold the same number of shares in KGaA as they hold in CompuGroup Medical SE prior to the change of legal form.